Royal Bank of Canada
ANRO icon

Royal Bank of Canada’s Alto Neuroscience ANRO Stock Holding History

Royal Bank of Canada’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
41
+7
+21% +$130 ﹤0.01% 6979
2025
Q4 		$1K Sell
34
-161
-83% -$2.03K ﹤0.01% 7065
2025
Q3 		$1K Sell
195
-11,889
-98% -$39.4K ﹤0.01% 7043
2025
Q2 		$26K Buy
12,084
+11,293
+1,428% +$26.9K ﹤0.01% 6185
2025
Q1 		$1K Sell
791
-535
-40% -$1.92K ﹤0.01% 6729
2024
Q4 		$6K Sell
1,326
-1,503
-53% -$9.38K ﹤0.01% 6509
2024
Q3 		$32K Buy
2,829
+1,995
+239% +$24.4K ﹤0.01% 5896
2024
Q2 		$9K Buy
+834
New +$10.9K ﹤0.01% 6402

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada's ANRO Position: Q1 2026 in Review

Royal Bank of Canada increased its Alto Neuroscience (ANRO) stake by 21% in Q1 2026, buying an estimated $130 and bringing the position to 41 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6979.

Royal Bank of Canada first reported a position in ANRO in Q2 2024 and has held it in 8 quarters since. The position peaked at $32K in Q3 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Royal Bank of Canada held 41 shares of Alto Neuroscience worth $1K as of Q1 2026.
  • Royal Bank of Canada bought 7 Alto Neuroscience shares in Q1 2026, an estimated $130.
  • Alto Neuroscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6979 holding.
  • Royal Bank of Canada first reported a position in Alto Neuroscience in Q2 2024 and has held it in 8 quarters since.
  • Royal Bank of Canada's Alto Neuroscience position peaked at $32K in Q3 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.